Akèy › Kansè ovè
Etid klinik pou Kansè ovè ap rekrite nan Etazini
263 etid pou Kansè ovè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX89 etid
- New York City, NY69 etid
- Boston, MA61 etid
- Los Angeles, CA50 etid
- Nashville, TN49 etid
- Arlington, VA46 etid
- Philadelphia, PA44 etid
- Columbus, OH39 etid
- St. Louis, MO38 etid
- Chicago, IL36 etid
- San Antonio, TX31 etid
- Cleveland, OH30 etid
- Pittsburgh, PA30 etid
- Seattle, WA30 etid
- Atlanta, GA29 etid
- Rochester, MN29 etid
- Dallas, TX28 etid
- Oklahoma City, OK28 etid
- Queens, NY28 etid
- Durham, NC27 etid
- Portland, OR27 etid
- Detroit, MI26 etid
- Aurora, CO25 etid
- Baldwin Park, CA25 etid
- Minneapolis, MN24 etid
- San Diego, CA24 etid
- Grand Rapids, MI24 etid
- Birmingham, AL23 etid
- Washington, DC23 etid
- Miami, FL23 etid
- Orlando, FL22 etid
- Baltimore, MD22 etid
- New Haven, CT21 etid
- Tampa, FL21 etid
- Edison, NJ20 etid
- Salt Lake City, UT19 etid
- Cincinnati, OH19 etid
- Mountain View, CA19 etid
- San Francisco, CA19 etid
- Milwaukee, WI17 etid
Pa eta
- Alabama27 etid
- Alaska7 etid
- Arizona26 etid
- Arkansas11 etid
- Ayiti7 etid
- Colorado44 etid
- Connecticut28 etid
- Delaware5 etid
- Distrik Columbia7 etid
- Florid81 etid
- Georgia35 etid
- Idaho4 etid
- Illinois49 etid
- Indiana23 etid
- Iowa10 etid
- Kalifòni105 etid
- Kansas10 etid
- Kentucky25 etid
- Lwizyàn19 etid
- Main9 etid
- Maryland40 etid
- Massachusetts67 etid
- Michigan50 etid
- Minnesota53 etid
- Mississippi6 etid
- Missouri41 etid
- Montana10 etid
- Nebraska15 etid
- Nevada11 etid
- New Hampshire4 etid
- New Jersey40 etid
- New Mexico16 etid
- New York96 etid
- North Carolina44 etid
- North Dakota7 etid
- Ohio70 etid
- Oklahoma31 etid
- Oregon34 etid
- Pennsylvania69 etid
- Rhode Island16 etid
- South Carolina17 etid
- South Dakota16 etid
- Tennessee55 etid
- Texas122 etid
- Utah29 etid
- Virginia57 etid
- Washington38 etid
- West Virginia10 etid
- Wisconsin29 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Oct 2, 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Ap rekriteEtid obsèvasyon
Laj 2 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06465069Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT04847063Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Oct 2, 2026 · NCT06885697A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06270706Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Ap rekriteEtid obsèvasyon
Laj 3 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT01441089Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Ap rekriteFaz 2
Laj 18 a 72 · Tout sèks · Mizajou Oct 2, 2026 · NCT01174121A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 19 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06586957A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Oct 1, 2026 · NCT07024784A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07189871TLR9 Immunotherapy for Peritoneal Carcinomatosis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07658196Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Oct 1, 2026 · NCT07851025Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT04751435The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07285044A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07278336A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07814248Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07360314First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06799065A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05877599A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Sep 29, 2026 · NCT05128825Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.